MBBS and other health courses exams postponed in this state

The exams for first, second and third year of health science courses, including MBBS, Ayurveda, homeopathy, etc.

51
Doctor
Picture: Pixabay

Last Updated on April 17, 2021 by The Health Master

Mumbai, Maharashtra: Exams for over 40,000 students from medical (MBBS) and other health science courses across Maharashtra, which were scheduled to commence from April 19, have now been postponed to June.

The decision has come in the wake of the surge in C-19 cases across the state. Students and parents were against the conduct of these exams amidst the pandemic.

The exams for first, second and third year of health science courses, including MBBS, Ayurveda, homeopathy, etc. conducted by the Maharashtra University of Health Sciences (MUHS) were already postponed twice before.


To read more articles on MBBS, click here


Medical Education Minister Amit Deshmukh announced the decision after consultation with the chief minister. The exam will now be held in June and the detailed schedule of the exam will be announced by MUHS soon.

Document
Picture: Pixabay

Ajit Pathak, exam controller from MUHS, said that the state has taken the decision considering the pandemic situation and appeals of students. The exam was earlier scheduled on March 23 and April 19. Final year MBBS exams have already been conducted by the state.

Brijesh Sutaria, a parent of a third-year student, said that he is happy with postponement as the students are facing a lot of difficulties in the hostels. Many are sharing accommodation, so it is inconvenient to study in the same confined place while following social distancing norms. There are students who are also down with C-19 who will be unable to appear for the exam at this stage.

Sudha Shenoy, a parent representative, said that June will be too late for the exams as it will have an impact on the subsequent academic sessions too.


Also read:

Good storage practice of Medicines at Medical Store

Govt approves stepping up of production of Remdesivir

IPC and USP India to setup drug standards, developing reference standards

Remdesivir should be supplied only to hospitals: NITI Aayog

Sputnik V vaccine: Dr Reddy’s working on storage temp. range

Gilead gets USFDA not to treat metastatic urothelial cancer

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner